Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Journal of Medical Microbiology|December 14, 2011
In vitro antibacterial activity of different adenosine analoguesLuca A Vitali, Dezemona Petrelli, Catia Lambertucci, et al.Frontiers in Pharmacology|March 30, 2018
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal DiseasesDiego Dal Ben, Luca Antonioli, Catia Lambertucci, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 8, 2003
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivitiesKarl-Norbert Klotz, Sonja Kachler, Catia Lambertucci, et al.Neuropharmacology|October 9, 2020
Efficacy of acetylcholinesterase inhibitors in Alzheimer's diseaseGabriella Marucci, Michela Buccioni, Diego Dal Ben, et al.Current Medicinal Chemistry|December 18, 2014
Medicinal chemistry of P2X receptors: agonists and orthosteric antagonistsCatia Lambertucci, Diego Dal Ben, Michela Buccioni, et al.Analytical and Bioanalytical Chemistry|September 11, 2012
Development of new chromatographic tools based on A2A adenosine receptor subtype for ligand characterization and screening by FAC-MSCaterina Temporini, Gabriella Massolini, Gabriella Marucci, et al.Current Medicinal Chemistry|March 2, 2022
Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative DisordersDaniela Catarzi, Flavia Varano, Erica Vigiani, et al.Bioorganic & Medicinal Chemistry|October 15, 2010
Molecular modeling study on potent and selective adenosine A(3) receptor agonistsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Bioorganic Chemistry|January 31, 2026
Adenine nucleotides as potent and selective GPR17 modulatorsDiego Dal Ben, Catia Lambertucci, Michela Buccioni, et al.Expert Opinion on Therapeutic Patents|April 7, 2022
A patent review of adenosine A2B receptor antagonists (2016-present)Beatrice Francucci, Diego Dal Ben, Catia Lambertucci, et al.Pageof 10